Skip to content

Add your earlier progress to your account?

From before you signed in, this browser has:

Which plan do you want to keep?

You answered the plan questions before signing in. These answers differ from the plan saved on your account.

SettingSaved planNew answers

Study progress is waiting to be saved

Blood Cultures and Gram-Positive Blood Isolates

About 17 min · 8 sections · 3 self-checks

On this page

A positive blood culture requires two linked steps. The laboratory identifies the organism and assesses whether the isolate represents bloodstream infection, contamination during collection, or growth from an intravascular device. That assessment depends on blood volume, the number and source of the sets, the bottle pattern, the time to detection, the Gram stain, and the final organism identification.1

Blood culture is the reference method for diagnosing bacteremia and common fungemia and remains central to the laboratory evaluation of endocarditis and other endovascular infections. Molecular methods can shorten identification after a bottle becomes positive. Culture provides the isolated organism needed for full identification and susceptibility testing.1,2

General specimen transport, direct stains, media, incubation, and staged reporting are covered in Specimen Collection, Transport, and Primary Processing in Microbiology. Blood cultures also require collection, monitoring, and interpretation steps that depend on the source, set, bottle pattern, and organism recovered.

Collection for bloodstream infection

Collect blood cultures before antimicrobial therapy when the patient's condition permits, because the drug can suppress growth in the bottle. Routine adult sets can be collected sequentially from separate peripheral venipunctures. Volume and aseptic collection are more important than a routine interval between sets. A separate protocol may specify timing when infective endocarditis or another continuous endovascular infection is being evaluated.3,2

Prepare the venipuncture site with an appropriate alcohol-containing skin antiseptic and disinfect each bottle septum with 70% isopropyl alcohol. Collect each set from a separately prepared site and document the date, time, anatomic site, collection method, and bottle fill volume.3

An adult blood-culture set contains 20 to 30 mL of blood, divided among the bottles required by the validated culture system. A common two-bottle set places about 10 mL into an aerobic bottle and 10 mL into an anaerobic bottle. Collect at least two sets, totaling 40 to 60 mL, within a 24-hour septic episode. The Centers for Disease Control and Prevention (CDC) describes two to four sets as the standard range. Blood volume has the largest controllable effect on adult recovery, because many bloodstream infections contain few organisms per milliliter.3,2

The bottle manufacturer defines the accepted fill range. Underfilling lowers sensitivity. Severe overfilling can disturb the blood-to-broth ratio and may cause instrument or interpretation problems. Monitor the measured fill volume for each bottle as a collection quality indicator.1,3

Pediatric volume is based on the child's weight, the total blood volume that can be drawn safely, and the instructions for the pediatric bottle. Small-volume collections commonly use one pediatric aerobic bottle. Older children who can supply an adult volume use the adult collection plan. The laboratory's weight-based table defines the volume for each pediatric range.2

Peripheral venipuncture is the preferred source. When catheter-related bloodstream infection is being evaluated, collect a peripheral set and a catheter-drawn set at the same time and label the source of each. Comparing the bottle patterns and time to detection from these paired sources helps distinguish line colonization, collection contamination, and bloodstream infection.1,2

Bacteremia pattern Common setting Collection implication
Transient Manipulation of an infected focus or contaminated mucosal surface; early spread from a localized infection Collect promptly around the suspected event.
Intermittent Periodic seeding from an incompletely drained focus Separate sets improve the chance of sampling an episode.
Continuous Endocarditis, infected vascular graft, or another endovascular focus Timing collection to fever has little value. Collect the prescribed sets promptly.

Bottle monitoring and positive-culture workup

Modern blood-culture bottles use enriched broth, an anticoagulant such as sodium polyanethol sulfonate, and formulation-specific systems that may bind or neutralize antimicrobial agents. A validated blood-to-broth ratio, commonly between about 1:5 and 1:10, dilutes complement, antibodies, phagocytes, and residual antimicrobial activity. Some bottles contain adsorbing resins for further antimicrobial neutralization. Automated instruments incubate the bottles and repeatedly measure a microbial metabolic signal, usually carbon dioxide production or a change in headspace gas pressure.1

Follow the incubation period validated for your bottle and instrument combination. A routine period of about 5 days recovers most bacteria and yeasts, including the HACEK organisms (Haemophilus, Aggregatibacter, Cardiobacterium, Eikenella, and Kingella) and Brucella species on a validated routine protocol without extended incubation. Suspected mycobacteremia, selected fungi, Cutibacterium acnes, and other unusual organisms may require a different bottle, system, or incubation plan.1,2 When brucellosis is clinically suspected, current American Society for Microbiology and Association of Public Health Laboratories sentinel-laboratory guidance extends incubation in automated systems to about 10 days. Consider a blind or terminal subculture when brucellosis remains suspected after negative bottles.4 Brucella is a biosafety level 3, laboratory-acquired-infection risk organism. When brucellosis is suspected, follow the laboratory's biosafety and public-health referral procedure.1,2

Most nonfastidious bloodstream isolates signal during the first 24 to 36 hours. Time to positivity is affected by organism burden, collected volume, bottle atmosphere, antimicrobial exposure, and transport delay. An early signal can support a high organism burden, and earlier growth from a catheter bottle can support a catheter source when compared with the paired peripheral bottle. Time to positivity is one part of the interpretation. Facultative organisms may signal in either an aerobic or anaerobic bottle, so bottle atmosphere alone is an unreliable predictor of detection time.1,2

When a bottle signals positive, work it up in this order:1,2

  1. Mix and sample the bottle with an aerosol-controlled procedure.
  2. Prepare a Gram stain and communicate the result through the laboratory's urgent-result policy.
  3. Inoculate solid media appropriate for the Gram-stain finding and bottle atmosphere.
  4. Apply a validated rapid identification method when available. A positive-bottle molecular panel can identify its listed targets and selected resistance genes. Validated mass-spectrometry workflows can shorten identification after adequate organism preparation.
  5. Confirm the identification and complete susceptibility testing through the laboratory's validated pathway, which may begin directly from positive broth or from an isolated colony. Resolve a disagreement between a resistance-gene result and the phenotype under the laboratory's validated policy.

Rapid identification is most useful when the laboratory communicates the result promptly and explains its limits. Each panel covers a fixed target list, so an unlisted organism or resistance mechanism remains possible. The Gram stain is available first and continues to guide culture work while a rapid assay is running.5

A flagged bottle with an initially negative Gram stain requires repeat staining and subculture. Organisms such as Brucella may stain faintly or be sparse. A false instrument signal can also occur without viable growth. When a high-risk organism is suspected, follow the laboratory's biosafety and public-health referral procedure.1,2

Positive blood-culture workflowA positive bottle signal prompts laboratory assessment and preliminary communication. Visible and nonvisible organisms follow the validated workup to resolve the signal. High-risk concerns override routine testing and trigger safe referral.Positive blood-culture workflowNotify promptly while identification continues.Instrument-positive signalPrompt laboratory assessmentReview Gram stain and signal context.Organisms seenUrgent preliminary notification.Proceed under the validatedidentification workflow.No organisms seenReview discordant findings.Use the laboratory's validatedrepeat staining and culture.Resolve the signalIdentify recovered organisms.Rapid testing may run in parallel.Finalize and communicateSusceptibility testing when indicated.Reconcile and update earlier reports.Safety override applies at every stageA high-risk organism concern stops routine workup.Secure the material and contact the laboratory supervisorand designated public-health reference laboratory.An instrument signal alone does not prove viable organisms.
From a positive blood-culture signal to final identification, with the urgent call and safety branches.

Contamination and clinical significance

The most common interpretive problem in blood culture is a single bottle growing a skin organism, which may represent infection or contamination. Coagulase-negative staphylococci, Corynebacterium species, Bacillus species other than B. anthracis, Micrococcus species, Cutibacterium acnes, and some viridans-group streptococci are common skin commensals. Each can also cause true infection, especially in a patient with an intravascular catheter, prosthetic valve, other implanted material, immunosuppression, or repeated recovery of the same organism.6

Culture pattern Interpretation supported by the pattern Required correlation
Same commensal species recovered from independently collected sets True bacteremia becomes more likely Species identification, susceptibility, clinical findings, and device history should agree.
Commensal species recovered from one set among two or more sets Collection contamination becomes more likely Low-grade bacteremia, antimicrobial exposure, and an intravascular device remain possible explanations.
Only one set collected and a commensal species grows Pattern evidence is unavailable Interpretation depends on clinical context, repeat cultures, source, and organism-level identification.
Staphylococcus aureus, beta-hemolytic streptococcus, Streptococcus pneumoniae, or Listeria monocytogenes recovered from blood The isolate usually represents a clinically important bloodstream pathogen Confirm identification promptly and complete the organism-specific workup.

The number of positive bottles within one set is weaker evidence than the number of independently collected sets. Bottle composition and organism oxygen preference influence which bottle becomes positive. Report the exact set and bottle pattern, and add a qualified comment that names a possible skin contaminant and calls for clinical correlation.3,6

The blood-culture contamination rate is a collection quality indicator. Laboratories track the percentage of eligible culture sets classified as contaminated and investigate a rising rate through collection location, collector, and technique data.6

Initial identification

The positive-bottle Gram stain determines where identification begins. Colony morphology and validated rapid reactions narrow the possibilities. Mass spectrometry, an automated system, or a molecular method provides the final identification.7

Gram-stain and colony clue First useful reaction Main group
Gram-positive cocci in clusters Catalase positive Staphylococcus and related catalase-positive cocci
Gram-positive cocci in pairs or chains Catalase negative Streptococcus, Enterococcus, and similar catalase-negative cocci
Pleomorphic, club-shaped, or palisading gram-positive rods Catalase commonly positive Corynebacterium and related coryneform rods
Small gram-positive rods or coccobacilli with narrow beta hemolysis Catalase positive and motile at room temperature Listeria monocytogenes
Slender coryneform rods with delayed beta hemolysis Catalase negative Arcanobacterium haemolyticum

Catalase testing requires a colony taken without blood-agar carryover because erythrocytes contain catalase and can produce a false-positive reaction.7

Staphylococcus from blood

Staphylococci are catalase-positive, facultatively anaerobic gram-positive cocci that usually form clusters. Mannitol salt agar selects salt-tolerant staphylococci and differentiates mannitol fermentation. It gives a presumptive screening pattern. Final identification uses a validated method.

Coagulase testing separates the principal phenotypic groups. The slide reaction detects bound coagulase or clumping factor, and the tube reaction detects free coagulase. Autoagglutinating strains require a saline control. Perform each procedure as validated for the reagent and the laboratory. Staphylococcus lugdunensis can produce clumping factor and can be slide-coagulase positive and tube-coagulase negative.7

Organism or group Identification clues Meaning in blood culture
S. aureus Coagulase positive; many isolates show clumping factor and protein A; beta hemolysis and golden pigment may occur; mass spectrometry or another validated system confirms the species Usually clinically significant, even when one set is positive; common in endovascular, catheter, bone, joint, and deep-tissue infection
S. lugdunensis Clumping-factor reaction may be positive; tube coagulase is negative; ornithine decarboxylase and pyrrolidonyl arylamidase reactions support older phenotypic schemes Greater invasive potential than most coagulase-negative staphylococci; identify a sterile-site isolate to species
Other coagulase-negative staphylococci Coagulase negative; species identification by mass spectrometry or a validated system Frequent contaminants; repeated matching isolates or recovery with a catheter, prosthetic valve, joint, or shunt supports infection

These findings provide a presumptive identification. The final report comes from a validated identification system.7

Methicillin resistance in S. aureus most often results from mecA, which encodes the altered penicillin-binding protein PBP2a. mecC and uncommon phenotypes can give results that disagree with an assay that detects only mecA. Cefoxitin, used in phenotypic testing, is a strong inducer of mecA and gives clear endpoints. Validated PBP2a immunoassays and mecA/mecC molecular assays are other methods for detecting resistance. The organism-specific method and breakpoint must match the current corrected Clinical and Laboratory Standards Institute (CLSI) M100 edition and your laboratory's validated system.8,9

An erythromycin-resistant, clindamycin-susceptible staphylococcal isolate requires assessment for inducible macrolide-lincosamide-streptogramin B resistance under the current CLSI method. In the D-zone test, induction appears as flattening of the clindamycin inhibition zone beside the erythromycin disk. Disk placement and interpretation follow the adopted M100 procedure.9

Vancomycin-intermediate S. aureus (VISA) has a vancomycin minimum inhibitory concentration (MIC) of 4 to 8 µg/mL. Vancomycin-resistant S. aureus (VRSA) has an MIC of at least 16 µg/mL. When an isolate has an MIC of at least 8 µg/mL, CDC directs the laboratory to verify culture purity, repeat species identification and MIC testing with a validated method, preserve the isolate, notify infection prevention and public health, and send the isolate through the health department for confirmatory testing. VISA and VRSA detection requires a validated MIC method because disk diffusion misses part of this range.10

Streptococcus and Enterococcus from blood

Streptococci and enterococci are catalase-negative gram-positive cocci that usually appear in pairs or chains. Hemolysis on sheep blood agar supplies the first presumptive classification. Lancefield carbohydrate grouping further classifies chiefly beta-hemolytic streptococci and selected group D organisms. Species identification is needed because hemolysis varies and a Lancefield antigen can occur in more than one species.7

Organism or group Presumptive laboratory pattern Blood-culture significance
Streptococcus pyogenes Usually beta hemolytic; group A antigen; pyrrolidonyl arylamidase positive Invasive bloodstream recovery is significant; throat-specific testing is covered in respiratory bacteriology
Streptococcus agalactiae Group B antigen; narrow beta hemolysis or a nonhemolytic variant; CAMP and hippurate reactions support identification Important cause of maternal, neonatal, and adult invasive infection; antenatal screening is covered in genital bacteriology
Group C and G streptococci Usually beta hemolytic; group antigen and a validated identification method resolve species such as S. dysgalactiae subsp. equisimilis Blood recovery can represent invasive skin, soft-tissue, respiratory, joint, or endovascular infection
Streptococcus pneumoniae Alpha-hemolytic, lancet-shaped diplococci; optochin susceptible and bile soluble in the classic presumptive scheme Blood recovery is significant and commonly accompanies pneumonia, meningitis, or other invasive pneumococcal disease
Viridans-group streptococci Alpha, gamma, or occasional beta hemolysis; optochin resistant and bile insoluble in the classic scheme One positive set may reflect oral or skin contamination; repeated recovery supports endovascular infection; recovery of the S. anginosus group also suggests an abscess source
Streptococcus gallolyticus group, historically the S. bovis group Commonly group D antigen, bile-esculin positive, pyrrolidonyl arylamidase negative, and no growth in 6.5% sodium chloride Accurate species and subspecies reporting matters because S. gallolyticus subsp. gallolyticus bacteremia has a strong association with endocarditis and colorectal neoplasia11
Enterococcus species Pyrrolidonyl arylamidase and bile-esculin positive; most grow in 6.5% sodium chloride; mass spectrometry or another validated system supplies species identification Common in health care-associated bacteremia and endocarditis; species identification directs resistance interpretation

The historical name S. bovis covers several organisms with different clinical associations. Current reporting uses the S. gallolyticus and S. infantarius group names when the identification method can resolve them. The accuracy of mass-spectrometry and biochemical systems depends on their database content. 16S ribosomal RNA sequencing often cannot resolve subspecies.11

Several less common catalase-negative cocci can be misidentified:

Organism Recognition clue Reporting consequence
Aerococcus species Cocci in tetrads or clusters that can resemble staphylococci on Gram stain; catalase negative Species identification distinguishes an invasive isolate from a viridans-like preliminary call
Abiotrophia and Granulicatella Pyridoxal-dependent growth, tiny satellite colonies near a helper organism, or growth on enriched media Weak or absent routine growth can obscure a cause of endocarditis
Gemella species Diplococci may decolorize and resemble gram-negative cocci; catalase is negative and colonies can resemble viridans streptococci A validated system prevents a preliminary Neisseria or viridans-group misidentification
Leuconostoc species Cocci or coccobacilli in pairs and chains; catalase negative; intrinsically vancomycin resistant Confirm the species after a vancomycin-resistant result before reporting an enterococcus
Pediococcus species Tetrads and pairs; catalase negative; intrinsically vancomycin resistant Species confirmation prevents an incorrect enterococcal identification

These uncommon cocci require species confirmation before a clinically important sterile-site report.7

Pneumococcal penicillin susceptibility can begin with the current 1-µg oxacillin screen. A zone of at least 20 mm supports penicillin susceptibility. A smaller zone requires MIC testing with meningitis or nonmeningitis breakpoints as appropriate. The exact zone and MIC criteria come from the laboratory's adopted, corrected CLSI M100 edition.9

Enterococcal vancomycin resistance has two major laboratory patterns. Acquired vanA and vanB resistance has important transmission and infection-prevention implications. Chromosomal vanC produces characteristic low-level intrinsic resistance in Enterococcus gallinarum and E. casseliflavus. Both species are motile. E. casseliflavus is commonly yellow-pigmented. E. gallinarum is usually nonpigmented. Use species identification and the complete susceptibility pattern to distinguish acquired from intrinsic resistance.9

Coryneform rods and Listeria

Irregular gram-positive rods recovered from blood range from common skin commensals to invasive and public-health pathogens. Gram-stain shape provides the first clue. Mass spectrometry, sequencing, or a validated biochemical system provides the reportable species identification.7,12-13

Organism or group Laboratory pattern Interpretation or action
Nondiphtherial Corynebacterium species Pleomorphic, club-shaped or palisading rods; catalase positive; colony appearance varies by species A single recovery commonly reflects skin contamination; matching independent sets, an intravascular device, immunosuppression, or species such as C. jeikeium or C. striatum supports species identification and a clinically directed susceptibility decision
Toxigenic-capable Corynebacterium group C. diphtheriae, C. ulcerans, and C. pseudotuberculosis require species identification plus toxin evaluation Coordinate immediately with the public-health laboratory; a toxin-production test is required after species identification and tox gene detection
Arcanobacterium haemolyticum Catalase negative coryneform rod; small colonies develop beta hemolysis; a reverse CAMP reaction shows reduced hemolysis beside an S. aureus streak Commonly associated with pharyngitis or wound infection; a sterile-site recovery requires confirmation by a validated method
Trueperella species Catalase-negative coryneform rods; T. pyogenes and T. bernardiae are opportunistic abscess and wound isolates Report under the current Trueperella name and confirm a significant sterile-site recovery
Listeria monocytogenes Small regular rods or coccobacilli; catalase positive; narrow beta hemolysis; tumbling motility at room temperature and umbrella motility in semisolid medium A blood or cerebrospinal-fluid isolate is significant; rapid recognition matters in pregnancy, neonates, older adults, and people with impaired cellular immunity
Erysipelothrix rhusiopathiae Slender gram-positive rods; catalase negative, nonmotile, nonhemolytic, and hydrogen sulfide positive in triple sugar iron agar These reactions separate it from Listeria when the initial rod morphology overlaps

The clinical context determines the workup for nondiphtherial Corynebacterium species. Recent clinical evidence identifies C. jeikeium and C. striatum as important causes of catheter-associated and other bloodstream infections, especially in patients with hematologic malignancy, neutropenia, or an implanted device. Repeated recovery from independent sets supports species-level identification. Phenotypic schemes can misidentify these organisms, so mass spectrometry or reference-laboratory testing is preferred when the local method cannot resolve them.12

Suspected diphtheria follows a three-part confirmation sequence: isolate and identify the organism, detect the tox gene, and demonstrate toxin production. In the United States, CDC currently performs the Elek immunoprecipitation test used to confirm toxin production. State and local public health laboratories coordinate submission. Diphtheria confirmation requires demonstrated toxin production.14

Listeria monocytogenes can resemble group B streptococcus because both may form small colonies with a narrow zone of beta hemolysis. The Gram stain shows a rod, and the positive catalase reaction separates it from group B streptococcus. Room-temperature motility and a validated identification system complete the workup. Cold enrichment is used chiefly in food and environmental investigation. Routine blood cultures use the laboratory's validated clinical system.13

L. monocytogenes has intrinsic clinical resistance to cephalosporins, so suppress an apparently susceptible cephalosporin result under your laboratory's organism-specific reporting rules. Susceptibility testing for Listeria and other infrequently isolated bacteria follows the current method and criteria adopted from CLSI M45 and related standards.15 At the bench, interpret every positive bottle with its set, its source, and its partner bottles before you report it.

Practice

Check yourself 1 of 3

Two adult blood-culture sets are drawn before antimicrobials by separate venipunctures 5 minutes apart. Each set holds about 3 mL of blood split between an aerobic and an anaerobic bottle. What most limits recovery?

Incorrect. Routine adult sets can be drawn sequentially, and volume and aseptic collection matter more than the interval between sets.

Correct. An adult set holds 20 to 30 mL, and blood volume has the largest controllable effect on recovery because many bloodstream infections contain few organisms per milliliter. About 3 mL per set is severe underfilling, and the measured fill volume is tracked as a collection quality indicator.

Incorrect. A two-bottle adult set routinely places about 10 mL in each of an aerobic and an anaerobic bottle. The split is standard, so the problem here is the 3-mL total.

Review this section

Check yourself 2 of 3

A coagulase-negative staphylococcus grows in one bottle of one set, and a second, independently collected set stays negative. What does the report convey?

Incorrect. The number of independently collected positive sets is more significant than the number of positive bottles within one set, and a commensal in one of two sets suggests contamination.

Correct. Recovery from one set among two makes collection contamination more likely. Low-grade bacteremia, antimicrobial exposure, and an intravascular device remain possible explanations. The report gives the exact set and bottle pattern and a comment naming a possible skin contaminant.

Incorrect. One positive set among two makes contamination more likely but does not confirm it. Coagulase-negative staphylococci can cause true infection, especially with a catheter or prosthetic device, so the comment stays qualified.

Review this section

Check yourself 3 of 3

A blood isolate of Staphylococcus aureus gives a vancomycin MIC of 8 µg/mL by a validated method. What does the laboratory do next?

Correct. For an MIC of 8 µg/mL or more, CDC directs the laboratory to verify purity, repeat identification and MIC testing, preserve the isolate, notify infection prevention and public health, and send it through the health department for confirmation. VISA is 4 to 8 µg/mL and VRSA 16 µg/mL or more.

Incorrect. Vancomycin disk diffusion misses part of the VISA and VRSA range, so confirmation uses a validated MIC method.

Incorrect. An MIC of 8 µg/mL falls in the VISA range of 4 to 8 µg/mL. At 8 µg/mL or more, the laboratory confirms purity, identification, and the MIC, then saves and refers the isolate before the result is final.

Review this section

References
  1. Clinical and Laboratory Standards Institute. Principles and Procedures for Blood Cultures. 2nd ed. CLSI guideline M47. Clinical and Laboratory Standards Institute; 2022. Accessed August 29, 2026. https://clsi.org/shop/standards/m47/ Back to text
  2. Miller JM, Binnicker MJ, Campbell S, et al. Guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2024 update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis. Published online March 5, 2024. doi:10.1093/cid/ciae104 Back to text
  3. Centers for Disease Control and Prevention. Collect adult blood culture sets. Updated March 31, 2026. Accessed August 29, 2026. https://www.cdc.gov/lab-quality/php/preventing-adult-blood-culture-contamination/collect.html Back to text
  4. American Society for Microbiology and Association of Public Health Laboratories. Brucellosis-causing Brucella species (BBS): Sentinel level clinical laboratory guidelines for suspected agents of bioterrorism and emerging infectious diseases. ASM; 2025. Accessed August 30, 2026. https://asm.org/guideline/brucellosis-causing-brucella-species-bbs-sentinel Back to text
  5. Wolk DM, Parrott JS, Babady NE, et al. The American Society for Microbiology's evidence-based laboratory medicine practice guidelines for the diagnosis of bloodstream infections using rapid tests: a systematic review and meta-analysis. Clin Microbiol Rev. 2025;38(3):e00137-24. doi:10.1128/cmr.00137-24 Back to text
  6. Sautter RL, Parrott JS, Nachamkin I, et al. American Society for Microbiology evidence-based laboratory medicine practice guidelines to reduce blood culture contamination rates: a systematic review and meta-analysis. Clin Microbiol Rev. 2024;37:e00087-24. doi:10.1128/cmr.00087-24 Back to text
  7. Carroll KC, Pfaller MA, Landry ML, McAdam AJ, Karlowsky JA, Patel R, Pritt BS, eds. Manual of Clinical Microbiology. 13th ed. ASM Press; 2023. Back to text
  8. Centers for Disease Control and Prevention. Laboratory testing for methicillin (oxacillin)-resistant Staphylococcus aureus. Updated June 27, 2025. Accessed August 29, 2026. https://www.cdc.gov/mrsa/php/laboratories/index.html Back to text
  9. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. 36th ed. CLSI supplement M100. Clinical and Laboratory Standards Institute; 2026. Accessed August 29, 2026. https://clsi.org/shop/standards/m100/ Back to text
  10. Centers for Disease Control and Prevention. Laboratory testing for vancomycin-resistant Staphylococcus aureus. Updated April 15, 2024. Accessed August 29, 2026. https://www.cdc.gov/staphylococcus-aureus/php/laboratories/index.html Back to text
  11. Putnam NE, Youn J, Wallace MA, et al. Comparative evaluation of current biochemical-, sequencing-, and proteomic-based identification methods for the Streptococcus bovis group. J Clin Microbiol. 2023;61(4):e01712-22. doi:10.1128/jcm.01712-22 Back to text
  12. Mitchell BI, Markantonis JE. An underestimated pathogen: Corynebacterium species. J Clin Microbiol. 2025;63(10):e01552-24. doi:10.1128/jcm.01552-24 Back to text
  13. Centers for Disease Control and Prevention. Listeria monocytogenes identification chart. Accessed August 29, 2026. https://reach.cdc.gov/sites/default/files/job-aids-resources/Listeria_monocytogenes_ID_Chart_Branded_508.pdf Back to text
  14. Centers for Disease Control and Prevention. Laboratory testing for diphtheria. Updated July 31, 2026. Accessed August 29, 2026. https://www.cdc.gov/diphtheria/php/laboratories/index.html Back to text
  15. Clinical and Laboratory Standards Institute. Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria. 3rd ed. CLSI guideline M45. Clinical and Laboratory Standards Institute; 2016. Accessed August 29, 2026. https://clsi.org/shop/standards/m45/ Back to text

End of Blood Cultures and Gram-Positive Blood Isolates

Where this connects

Back to top ↑

Saved lessonsReview and reuse

Enlarged figure